In previous studies we noted reduced growth of Src-transformed fibroblasts and human breast cancer cells in subcutaneous and orthotopic sites respectively, when Tks5 expression levels were reduced [19, 21]. This evidence concerns the gene SH3PXD2A and breast carcinoma.